Dallas, TX -- (SBWIRE) -- 01/10/2012 -- Veterinary health products can be can be categorized into three main modalities: veterinary pharmaceuticals, biologicals and medicated feed additives (MFAs). 63% of the $21.1 billion veterinary health market in 2011 is accounted for by pharmaceuticals ($13.3 billion), 25% by biologicals ($5.27 billion) and 12% by medicinal feed additives ($2.5 billion). Food animal healthcare comprised $12.45 billion of the total 2011 market; companion animal healthcare comprised $8.64 billion.
The "Veterinary Health Market" report examines companies manufacturing veterinary health equipment and supplies in the world. Companies covered include: Abaxis, Abbott, Adiagene, Adisseo France, Alpharma, Avian, BASF, Bayer, Biobest, Biocurex, BioVet, Boehringer Ingelheim, CEVA Sante Animale, CJ, Cyprus, Dabaco Viet Nam, DayMoon, Dow AgroSciences, DuPont Qualicon, ECO, EIPICO, Elanco, Eurofins Medigenomix GmbH, Eurovet Animal Health, Gene Check, Heska, Huvepharma, Idexx, IWAKI & Co., Jansen, Laboklin, Medika, Merck & Co., Merial, MetaMorphix, Microbix, Momina krepost AD Veliko Tarnovo, Mosaic, Neogen, Norbrook, Novartis, Novus International, OptiGen, Orion, PETCO, PetSmart, PAHC, Phylaxia 1912 Holding NyRt, Piedmont, Pfizer, Prionics AG, Randox, Sanofi-Aventis, Sequent Scientific, Skystar, Sunwin International Nutraceuticals, Synbiotics, Teva, The Arab Pesticides and Veterinary Drugs Mfg. Co., ThermoGenesis, VCA Antech, Velefarm ad Beograd, Veterinarski Zavod Subotica ad Subotica, Vetoquinol, Virbac and Woogene.
This report provides a detailed analysis of the global veterinary health market, including:
- common diseases in cattle, pigs, poultry, dogs, cats and horses
- veterinary non-steroid anti-inflammatory drugs (NSAIDs)
- antibiotics
- veterinary antifungal drugs
- veterinary anthelmintics (parasiticides)
- veterinary biologics (vaccines)
- veterinary diagnostics
- animal feed additives